A New Jersey-based pharmaceutical company issued a voluntary recall for over half a million bottles of Prazosin Hydrochloride after clinical tests revealed that the capsules contain high levels of potentially cancer-causing chemicals.
The Food and Drug Administration released an enforcement report to announce that Teva Pharmaceuticals USA Inc. recalled a total of 580,844 bottles of blood pressure medication, commonly known as Prazosin Hydrochloride, which were distributed around the country.
